Evidence supporting the use of: Mevinolin
For the health condition: Strokes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Mevinolin, also known as lovastatin, is a member of the statin class of medications primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease. There is scientific rationale supporting the use of statins, including mevinolin, in the secondary prevention of stroke, particularly ischemic stroke, due to their ability to lower low-density lipoprotein (LDL) cholesterol and provide pleiotropic effects such as improving endothelial function and reducing inflammation. Several large clinical trials, such as the Heart Protection Study (HPS) and the SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) trial, have demonstrated that statins can modestly reduce the risk of recurrent stroke and major cardiovascular events in patients with a history of cerebrovascular disease.

However, the evidence specifically for mevinolin (lovastatin) in stroke prevention is less robust than for other statins like atorvastatin or simvastatin, which have been more extensively studied. Current guidelines recommend statin therapy in general for secondary prevention in stroke patients with atherosclerotic disease, but do not specifically prioritize mevinolin over other statins. The overall strength of evidence for statins in reducing stroke risk is moderate, but for mevinolin specifically, the direct evidence is limited, leading to a moderate evidence rating of 2 out of 5.

More about Mevinolin
More about Strokes

Products containing Mevinolin

We currently have no products on Vitabase that contain this ingredient.